4519 — Chugai Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual cashflow statement for Chugai Pharmaceutical Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	—	IFRS	—	IFRS	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	302,995	374,429	325,472	387,317	—
Depreciation
Amortisation
Non-Cash Items	133,165	167,061	101,347	165,197	-3,881
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-187,402	-328,812	-48,635	-136,579	390,161
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	279,626	244,112	409,924	447,600	386,280
Capital Expenditures	-72,866	-71,239	-74,258	-54,899	-111,607
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-46,061	-74,755	36,968	-172,466	-89,666
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-118,927	-145,994	-37,290	-227,365	-201,273
Financing Cash Flow Items	-47	-58	-81	233	-427
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-107,408	-145,641	-139,331	-141,006	-307,886
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	55,419	-45,584	236,505	81,528	-113,600